Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some…

AstraZeneca is investing heavily in US facilities to counteract tariff impacts, planning substantial growth through local manufacturing by 2030…

AstraZeneca PLC (LSE:AZN) has announced plans to invest $50 billion in the United States by 2030, marking the pharmaceutical giant’s…

AstraZeneca announces $50 billion US investment in manufacturing and R&D…

AstraZeneca pledges $50 bln investment in US as pharma tariffs loom…

AstraZeneca announced that it will invest $50 billion in the U.S. by 2030, including a multi-billion-dollar manufacturing site in Virginia.…

Der schwedisch-britische Pharmakonzern AstraZeneca kündigt Milliarden-Investitionen in den USA an – und macht dabei kein Geheimnis daraus, dass Zeitpunkt und…

…

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on…

AstraZeneca announces largest ever investment in U.S. manufacturing…

Astrazeneca (AZN) closed the most recent trading day at $69.26, moving 1.17% from the previous trading session.…

AZNs anselamimab fails to meet key goals in late-stage AL amyloidosis trials despite signs of subgroup benefit.…

AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study…

AstraZeneca on Wednesday said that its experimental drug anselamimab did not meet the main goal of a late-stage study for…

ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat Astrazeneca auf "Buy" mit einem Kursziel von 14200 Pence belassen. In…

LONDON (dpa-AFX Broker) - Positive Studiendaten zu einem Medikament von Astrazeneca sind am Montag an der Londoner Börse gut…

Shares in AstraZeneca PLC (LSE:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) were both down over 1% on Friday, but the shares are worth buying, analysts…